Wyman et al.
JOCArticle
color change and a concomitant formation of a white pre-
cipitate were noted. The reaction mixture was maintained
at -78 °C for 30 min and was then removed from the cold
bath and warmed to room temperature at which point
the solids were removed by filtration through a medium
porosity sintered-glass funnel. The filtrate was concen-
trated by rotary evaporation and the residue was dissolved
in pentane (∼20 mL) and decanted away from an insoluble
red oil. The pentane was removed in vacuo to provide 1-(2-
chlorohept-6-en-2-yl)-2-(4-chlorophenyl)diazene (12e0) in
80% yield. This material was used in the subsequent step
without further purification. Residual DMSO could be re-
moved by washing the pentane solution with water before
concentrating, but this step was not routinely performed as it
lowered product recovery and was not necessary for the
J = 17.1, 9.79, 7.5 Hz, 1H), 4.96-5.07 (m, 2H), 2.50 (d, J =
15.5 Hz, 1H), 2.30 (d, J = 15.5 Hz, 1H), 1.96-2.1 (m, 2H),
1.91 (s, 3H), 0.95 (s, 3H), 0.92 (s, 3H); 13C NMR (125 MHz,
CDCl3) δ 149.2, 137.4, 135.0, 129.4, 124.3, 117.6, 96.6, 53.7,
48.5, 34.8, 31.6, 28.5, 28.4.
1-(2-Chlorohept-6-en-2-yl)-2-(3-nitrophenyl)diazene (12h0).
Yield 75%; 1H NMR (500 MHz, CDCl3) δ 8.57 (s, 1H), 8.34
(d, J = 8.2 Hz, 1H), 8.14 (d, J = 8.2 Hz, 1H), 7.70 (t, J = 8.2
HZ, 1H), 5.80 (ddt, J = 17.0, 10.2, 6.9 Hz, 1H), 4.95-5.06 m
(2H), 2.31 (ddd, J = 14.1, 11.8, 4.7 Hz, 1H), 2.21 (ddd, J =
14.4, 11.9, 4.6 Hz, 1H), 2.09 (q, J = 6.9 Hz, 2H), 1.93 (s, 3H),
1.59-1.71 (m, 1H), 1.44-1.55 (m, 1H); 13C NMR (125 MHz,
CDCl3) δ 151.3, 148.9, 137.8, 130.1, 129.4, 125.4, 117.0,
115.2, 96.5, 42.0, 33.3, 28.7, 23.4.
1-(2-Chlorohept-6-en-2-yl)-2-(4-methoxyphenyl)diazene (12i0).
Yield 82%; 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 8.8 Hz,
2H), 6.97 (d, J = 8.8 Hz, 2H), 5.78 (ddt, J = 17.1, 10.2, 6.7 Hz,
1H), 5.01 (app d, J = 17.2 Hz, 1H), 4.93-4.98 (app d, J = 10.4
Hz, 1H), 3.87 (s, 3H), 2.27 (ddd, J= 14.2, 12.0, 4.7 Hz, 1H), 2.16
(ddd, J = 14.1, 11.9, 4.7 Hz, 1H), 2.09 (q, J = 7.0 Hz, 2H), 1.88
(s, 3H), 1.58-1.70 (m, 1H), 1.46-1.57 (m, 1H); 13C NMR (125
MHz, CDCl3) δ 162.2, 145.1, 138.2, 124.9, 115.0, 114.1, 96.5,
55.6, 42.4, 33.5, 28.8, 23.5.
1
subsequent transformation. H NMR (500 MHz, CDCl3) δ
7.75 (dm, J = 8.6, 1.9 Hz, 2H), 7.48 (dm, J = 8.6, 1.9 Hz, 2H),
5.78 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 5.01 (app dq, J = 17.0,
1.6 Hz, 1H), 4.95-4.98 (m, 1H), 2.28 (ddd, J = 14.0, 12.0, 4.7
Hz, 1H), 2.17 (ddd, J = 14.0, 12.0, 4.6 Hz, 1H), 2.09 (q, J =
7.3 Hz, 2H), 1.89 (s, 3H), 1.60-1.70 (m, 1H), 1.44-1.53 (m,
1H); 13C NMR (125 MHz, CDCl3) δ 149.3, 138.0, 137.3,
129.3, 124.2, 115.1, 96.5, 42.2, 33.4, 28.7, 23.4.
IV. Characterization Data for 4-Chlorophenyl-r-chloroazo
Alkanes. (E)-1-((Z)-2-Chlorooct-6-en-2-yl)-2-(4-chlorophenyl)-
diazene (12a0). Yield 83%; 1H NMR (500 MHz, CDCl3) δ 7.72
(d, J = 8.6 Hz, 2H), 7.45 (d, J = 8.6 Hz, 2H), 5.44-5.50 (m,
1H), 5.32-5.38 (m, 1H), 2.28 (ddd, J = 14.1, 11.9, 4.7 Hz, 1H),
2.17 (ddd, J = 14.1, 11.9, 4.7 Hz, 1H), 2.08 (q, J = 7.3 Hz, 2H),
1.89 (s, 3H), 1.54-1.68 (m, 1H), 1.59 (d, J= 6.7 Hz, 3H), 1.41-
1.50 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 149.3, 137.3,
129.7, 129.3, 124.6, 124.2, 96.5, 42.3, 28.7, 26.5, 24.1, 12.8.
1-(2-Chloro-7-methyloct-6-en-2-yl)-2-(4-chlorophenyl)diazene
(12b0). Yield 87%; 1H NMR (500 MHz, CDCl3) δ 7.71 (d, J =
8.6 Hz, 2H), 7.45 (d, J = 8.6 Hz, 2H), 5.08 (t, J = 7.1 Hz, 1H),
2.25 (ddd, J= 14.0, 11.8, 4.5 Hz, 1H), 2.16 (ddd, J= 14.0, 11.8,
4.6 Hz, 1H), 2.01 (q, J = 7.3 Hz, 2H), 1.89 (s, 3H), 1.68 (s, 3H),
1.58 (s, 3H), 1.55-1.65 (m, 1H), 1.40-1.47 (m, 1H); 13C NMR
(125 MHz, CDCl3) δ 149.3, 137.2, 132.0, 129.2, 124.2, 123.8,
96.5, 42.4, 28.6, 27.7, 25.6, 24.4, 17.7.
(E)-Methyl 7-Chloro-7-((E)-(4-chlorophenyl)diazenyl)oct-
2-enoate (12c0). Yield 69%; 1H NMR (500 MHz, CDCl3) δ
7.72 (d, J = 8.6 Hz, 2H), 7.45 (d, J = 8.6 Hz, 2H), 6.94 (dt,
J = 15.7, 7.0, Hz, 1H), 5.83 (dt, J = 15.7, 1.5 Hz, 1H), 3.72 (s,
3H), 2.30 (ddd, J = 14.0, 11.8, 4.6 Hz, 1H), 2.25 (qd, J = 7.3,
1.4 Hz, 2H), 2.18 (ddd, J = 14.1, 12.9, 4.6 Hz), 1.89 (s,
3H),1.68-1.78 (m, 2H), 1.51-1.63 (m, 2H); 13C NMR (125
MHz, CDCl3) δ 167.3, 149.6, 148.6, 137.8, 129.7, 124.6,
121.9, 96.4, 51.8, 42.9, 42.5, 32.1, 31.7, 30.3, 29.1, 23.0, 22.2.
1-(3-Chloro-2-methyloct-7-en-3-yl)-2-(4-chlorophenyl)diazene
(12f0). Yield 95%; 1H NMR (500 MHz, CDCl3) δ 7.71 (d, J =
8.6 Hz, 2H), 7.45 (d, J = 8.6 Hz, 2H), 5.74 (ddt, J = 16.9, 10.2,
6.7 Hz, 1H), 4.95 (app dq, J = 17.1, 1.7 Hz, 1H), 4.92-4.96 (m,
1H), 2.65 (septet, J = 6.71 Hz, 1H), 2.37 (ddd, J = 14.1, 11.8,
4.6 Hz, 1H), 2.20 (ddd, J = 14.0, 12.0, 4.4 Hz, 1H), 2.05 (q, J =
7.2 Hz, 2H), 1.55-1.64 (m, 1H), 1.21-1.30 (m, 1H), 1.15 (d,
J= 6.8 Hz, 3H), 0.94 (d, J=6.8Hz, 3H);13C NMR (125 MHz,
CDCl3) δ 149.3, 138.0, 137.1, 129.3, 124.1, 115.0, 104.2, 39.3,
37.7, 33.5, 22.9, 17.5, 17.4.
(E)-1-(2-Chlorooct-7-en-2-yl)-2-(4-chlorophenyl)diazene (24).
Yield 60%; 1H NMR (500 MHz, CDCl3) δ 7.71 (d, J = 8.7 Hz,
2H), 7.45 (d, J = 8.6 Hz, 2H), 5.78 (ddt, J = 16.9, 10.1, 6.8 Hz,
1H), 4.90-5.04 (m, 2H), 2.24-2.32 (m, 1H), 2.13-2.20 (m,
1H), 2.01-2.10 (m, 2H), 1.89 (s, 3H), 1.51-1.59 (m, 1H), 1.37-
1.46 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 149.7, 138.8,
137.7, 129.7, 124.6, 115.0, 96.9, 43.0, 33.8, 29.1, 29.0, 24.0.
V. Representative Experimental Procedures for the Formation
of Bicyclic Diazenium Salts. Method A: Lewis acid-mediated
formation of bicyclic diazenium salts from R-chloroazo
compounds:
6a-Methyl-2-(4-chlorophenyl)-3,3a,4,5,6,6a-hexahydrocyclo-
penta[c]pyrazol-2-ium Hexachlorostibate(V) (13e0). Antimony
pentachloride (3.56 mmol, 0.455 mL, 1 equiv) was added drop-
wise to a stirred solution of the R-chloroazoalkane 12e0 (3.56
mmol, 0.965 g, 1 equiv) in CH2Cl2 (40 mL) at -60 °C under a
nitrogen atmosphere. The cooling bath was allowed to warm
slowly to 0 °C (∼45 min) and the reaction was maintained
at that temperature for 1 h. The mixture was allowed to stir
at room temperature for 10 min at which point the solvent
was removed in vacuo to provide a dark oil or foam. This crude
material was analyzed by proton NMR (CD3CN) to determine
the ratio of fused to bridged diazenium salt products. The NMR
sample was recombined with the crude reaction mixture, the
solvent was removed in vacuo, and the residue was triturated
with Et2O to provide the desired diazenium salt as a powder in
92% yield: 1H NMR (500 MHz, CD3CN) δ 8.09 (d, J = 9.1 Hz,
2H), 7.76 (d, J = 9.3 Hz, 2H), 5.54 (dd, J = 17.2, 9.2 Hz, 1H),
5.13 (dd, J = 17.2, 4.5 Hz, 1H), 2.92-2.97 (m, 1H), 2.45-2.54
(m, 1H), 2.03-2.17 (m, 2H), 1.80 (s, 3H), 1.72-1.82 (m, 2H),
1.45-1.56(m,1H);13C NMR (125 MHz, CDCl3) δ143.8, 139.1,
131.7, 126.7, 101.2, 78.0, 43.2, 39.8, 33.7, 25.1, 23.8; observable
resonances for minor isomer: 6-(4-chlorophenyl)-1-methyl-6,7-
diazabicyclo[3.2.1]oct-6-en-6-ium hexachlorostibate(V) (14e0):1H
NMR (500 MHz, CD3CN) δ 8.09 (d, J = 6.6 Hz, 2H), 7.79 (d,
J = 6.1 Hz, 2H), 6.05 (app t, J = 5.1 Hz, 1 H), 1.87 (s, 3H); 13C
NMR (125 MHz, CD3CN) δ 144.6, 132.3, 87.5, 83.7, 29.4, 22.9,
22.6, 18.4; IR (ATR, cm-1) 1586, 1529, 1413, 1095, 831; MS (ESI)
calcd for [C13H16ClN2]þ 235.1002, found 235.0998.
1-(2-Chloro-4,4-dimethylhept-6-en-2-yl)-2-(4-chlorophenyl)-
diazene (12g0). Yield 86%; 1H NMR (500 MHz, CDCl3)
δ 7.75 (d, J = 8.6 Hz, 2H), 7.48 (d, J = 8.6 Hz, 2H), 5.81 (ddt,
J. Org. Chem. Vol. 75, No. 23, 2010 8085